The Street’s Key Stock Analysts Research Reports


Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of The Street’s Key analysts outlook for Key issues for Monday as follows:

Archer Daniels Midland Co. (NYSE:ADM) was raised to Buy from Hold at Stifel. The consensus target price is at 53.40.

AutoZone Inc. (NYSE:AZO) was downgraded to Perform from Outperform at Oppenheimer. Shares trade in a 52-wk range of 590.76 – 896.03. The stock has a consensus price target of 919.00.

Cimarex Energy Co. (NYSE:XEC) was raised to Positive from Neutral and the target price was raised to 88 from 74 at Susquehanna.

CRISPR Therapeutics A.G. (NASDAQ:CRSP) was started with a Buy rating and assigned a 43 target price at BTIG.

Editas Medicine Inc. (NASDAQ:EDIT) was started with a Buy rating and assigned a 30 price target at BTIG.

Grubhub Inc. (NYSE:GRUB) was raised to Buy from Neutral at Merrill Lynch, and Roth Capital also raised it to Buy from Neutral. Shares trade in a 52-wk range of 66.62 – 149.35 and a consensus analyst target of 114.73

Twitter Inc. (NYSE:TWTR):Wedbush maintained Twitter as Neutral with a 37 price target. Morgan Stanley maintained an Equal Weight rating and lowered its target to 31 from 33.

Have a terrific week.

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

You must be logged in to post comments :